Friday, February 27, 2026

Xebec Adsorption: BMO Cuts Price Target To Just $0.85 After Poor Q2 Margins

Xebec Adsorption (TSX: XBC) yesterday announced its second quarter financial results. The company announced revenues of $44.5 million, up from $40.33 million last quarter, while gross margins came in at $1.8 million, or just a 4% margin, compared to a 15% margin a year ago. The company also reported wider adjusted EBITDA and net losses for the quarter. Adjusted EBITDA came in at ($12) million, while the net loss amounted to $23.4 million.

The firm said they continue to amass a backlog of sales, growing to $270.2 million as of August 10, a jump of $9.7 million since May.

Xebec currently has 12 analysts covering the stock with an average 12-month price target of C$1.48, or an upside of about 150%. Out of the 12 analysts, two have buy ratings, nine have hold ratings, and the last analyst has a sell rating on the stock. The street high price target sits at C$3, representing an upside of 400%.

In BMO Capital Markets’ note on the results, they reiterate their market perform rating while lowering their 12-month price target from C$1.75 to C$0.85, saying that after incorporating the results, they have lowered their estimates and price.

On the results, BMO says that if you back out the one-time charge of $8.3 million, the results generally came in line with their estimates other than adjusted EBTIDA, which was expected to come in at ($3.7) million but came in at ($12) million. However, both systems and support revenues came in line with their estimates.

As a result of the quarter, BMO has now lowered their full year 2022 estimates. They now expect adjusted EBITDA to be ($26) million, worse than the ($12) million estimate prior. They also expect Xebec to see their adjusted EBITDA to grow to $8 million in 2023, down from their $12 million estimate prior.

They caution investors, saying, “We continue to take a more cautious stance until the company can
show some margin improvement.”

Below you can see BMO’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Can the World Actually Supply $6 Copper? | Greg Ferron – PTX Metals

1911 Gold: The Power Of A Mine Restart

Is Gold Repeating the 2005 Setup Before The Big Run? | Geordie Mark

Recommended

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver

Steadright: Atrium Research Initiates Coverage With $0.50 Price Target

Related News

K92 Mining Sees BMO Reiterate $11 Price Target

On November 15th, K92 Mining Inc. (TSX: KNT) reported its third quarter earnings. The company...

Saturday, November 20, 2021, 12:17:00 PM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

PLBY Group: Canaccord Nearly Doubles Price Target

PLBY Group (NASDAQ: PLBY) reported their first quarter financial results earlier this week. The company...

Friday, May 14, 2021, 06:12:00 PM

Raymond James: Village Farms Expected To Post 15% Revenue Increase In Q3

Last night, Raymond James came out with their third quarter estimates for Village Farms (TSX:...

Friday, October 23, 2020, 10:50:08 AM

Columbia Care: Canaccord Reiterates Price Target Following Project Cannabis Acquisition Announcement

Last Tuesday, Columbia Care (CSE: CCHW) announced that they had signed a definitive agreement to...

Sunday, September 13, 2020, 11:17:00 AM